Dissertations / Theses on the topic 'Heart – Differentiation'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 45 dissertations / theses for your research on the topic 'Heart – Differentiation.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Litster, Caroline Elizabeth. "Heart rate, heart rate variability, electrodermal activity and the differentiation-of-deception /." Title page, table of contents and abstract only, 2002. http://web4.library.adelaide.edu.au/theses/09SSPS/09sspsl7769.pdf.
Full textHinds, Heather C. "Evaluating terminal differentiation of porcine valvular interstitial cells in vitro." Link to electronic thesis, 2006. http://www.wpi.edu/Pubs/ETD/Available/etd-050506-113014/.
Full textO'Brien, Meghan M. "A pilot proteomic analysis : the study of P19 cells in cardiac differentiation /." Connect to resource online, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=ysu1229374725.
Full textBuccini, Stephanie M. "Cardiogenic differentiation of induced pluripotent stem cells for regeneration of the ischemic heart." University of Cincinnati / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1382373160.
Full textYounce, Craig. "Zinc-Finger Protein MCPIP in Cell Death and Differentiation." Doctoral diss., University of Central Florida, 2009. http://digital.library.ucf.edu/cdm/ref/collection/ETD/id/2279.
Full textPh.D.
Department of Biomolecular Science
Burnett College of Biomedical Sciences
Biomedical Sciences PhD
Wei, Wenjie, and 魏闻捷. "Calcium signaling in the cardiac differentiation of mouse embryonic stem cells." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B49617862.
Full textpublished_or_final_version
Physiology
Doctoral
Doctor of Philosophy
Chau, Dinh Le Mary. "Role of Notch1 in Cardiac Cell Differentiation and Migration: A Dissertation." eScholarship@UMMS, 2007. https://escholarship.umassmed.edu/gsbs_diss/338.
Full textMaliken, Bryan D. B. A. "Gata4-Dependent Differentiation of c-Kit+ Derived Endothelial Cells Underlies Artefactual Cardiomyocyte Regeneration in the Heart." University of Cincinnati / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1535375861364685.
Full textHuang, Tianfang. "Mechanism of Arsenical Toxicity on TGFβ Signaling and Genetic Regulation During Cardiac Progenitor Cell Differentiation." Diss., The University of Arizona, 2015. http://hdl.handle.net/10150/556428.
Full textMomtahan, Nima. "Extracellular Matrix from Whole Porcine Heart Decellularization for Cardiac Tissue Engineering." BYU ScholarsArchive, 2016. https://scholarsarchive.byu.edu/etd/6225.
Full textSargent, Carolyn Yeago. "Effects of hydrodynamic culture on embryonic stem cell differentiation: cardiogenic modulation." Diss., Georgia Institute of Technology, 2010. http://hdl.handle.net/1853/34710.
Full textMaddali, Kamala Kalyani. "A mandatory requirement of PKC-[delta] in testosterone regulated coronary smooth muscle cell differentiation, proliferation and apoptosis /." Free to MU Campus, others may purchase, 2005. http://proquest.umi.com/pqdweb?did=1232392431&sid=1&Fmt=2&clientId=45247&RQT=309&VName=PQD.
Full textHenje, Blom Eva. "Anxiety and depression in adolescent females autonomic regulation and differentiation /." Stockholm, 2010. http://diss.kib.ki.se/2010/978-91-7409-807-5/.
Full textSHELTON, ELAINE L. "Thr roles of Twist1 and Tbx20 in endocardial cell proliferation, migration, and differentiation during endocardial cushion development." University of Cincinnati / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1212062811.
Full textFarouz, Yohan. "Designing biomaterials for controlled cardiac stem cell differentiation and enhanced cell therapy in the treatment of congestive heart failure." Thesis, Sorbonne Paris Cité, 2015. http://www.theses.fr/2015USPCB114/document.
Full textCell therapy is a promising strategy to help regenerate the damaged heart. Recent studies have placed a lot of hopes in embryonic stem cells and our lab had previously found a way to differentiate them into cardiac progenitors, cells that can only differentiate into cardiomyocyte, endothelial cells or smooth muscle cells. This early commitment decreases their proliferative capabilities, yet maintains their plasticity for better integration inside the host tissue. However, clinical and pre-clinical injection studies did not really meet the expectations. Even though slight improvements in cardiac function were demonstrated, very low cell viability has been observed, as well as a very low retention of the cells inside the myocardium. To address this problem, my PhD projects not only focus on the design of new biomaterials to act as a vehicle for cell delivery and retention in the infarcted area, but also on the design of biomaterials that control the cellular environment during the differentiation of pluripotent stem cells into cardiomyocytes. Going back and forth between the labs and the clinics, we first developed new techniques for the fabrication and the characterization of a cell-laden fibrin patch that is now undergoing phase I clinical trial. From the approved clinical formulation, we then propose new blends of clinical materials that will eventually improve the maturation of the cardiac progenitors once grafted onto the failing heart. In this perspective, we developed an in vitro model to investigate the combined influence of matrix elasticity and topographical confinement on stem cell differentiation into cardiomyocytes. By using microfabrication techniques to pattern pluripotent stem cells on substrates of controlled stiffness, we demonstrate that even using a widely recognized chemical-based protocol to modulate signaling cascades during differentiation, much heterogeneity emerges depending on the cellular physical environment. We thus extracted the main features that led to controlled and reproducible cardiac differentiation and applied it to the fabrication of next generation of multi-layered anisotropic cardiac patches in compliances with clinical requirements. This work opens new routes to high-scale production of cardiomyocytes and the fabrication of cell-laden or cell-free clinical patches
Olson, Erik Ryan. "Signaling mechanisms controlling the proliferation and differentiation of cardiac fibroblasts." [Kent, Ohio] : Kent State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=kent1162230649.
Full textTitle from PDF t.p. (viewed Jan. 11, 2007 ) Advisor: J Gary Meszaros. Keywords: cardiac fibroblast, angiotensin II, fibrosis, MAPK Includes bibliographical references (p. 150-168).
Swinarski, Marie. "PCP-driven cardiac remodeling couples changes in actomyosin tension with myocyte differentiation." Doctoral thesis, Humboldt-Universität zu Berlin, Lebenswissenschaftliche Fakultät, 2017. http://dx.doi.org/10.18452/17775.
Full textFormation of a complex multiple-chambered heart from the simple linear heart tube does not only require orchestrated morphogenesis of the myocardium, but also cardiac muscle differentiation and changes in intercellular electrical coupling. To date, the processes that lead to the formation of a functional syncytium are incompletely understood. One of the major pathways controlling multiple aspects of organogenesis and tissue morphogenesis is the planar cell polarity (PCP) pathway. Changes in tissue architecture are controlled by cell intercalation and collective cell migration. It is widely accepted that Wnt/PCP signaling plays a crucial role in guiding these cellular processes. This study provides evidence that morphogenesis of the heart is controlled by the non-canonical ligands Wnt11 and Wnt5b and the PCP core components Fzd7, Vangl2, Dvl2, and Pk1 through regulation of cell rearrangements during embryonic cardiac remodeling. Downstream effectors of the PCP pathway target adhesion processes, cytoskeleton, and migration. Here, it is revealed that PCP signaling in the heart affects cardiomyocyte morphology and actomyosin organization. Specifically, changes in the subcellular localization of the phosphorylated non-muscle myosin II regulatory light chain (pMRLC) at LHT stage are targeted by the PCP pathway core components. Furthermore, actomyosin relocalization concurs with changes in nuclear tension and SRF signal transduction within the myocardium. This study unravels a novel function of the PCP core component Pk1 in regulation of SRF translocation and target gene expression that is critical to cardiac maturation. Taken together, this study provides evidence that the PCP pathway is a major regulator of cardiac remodeling and organ maturation by modulating mechanosensitive SRF signal transduction involved in muscle differentiation.
Self, Magdalen Romany Rowen. "Repair of a wounded heart : an investigation into the effects of aggregation on the differentiation of stem cells to cardiomyocytes." Thesis, University of Nottingham, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.523583.
Full textDi, Guglielmo Claudia. "Biotechnological approaches to cardiac differentiation of human induced pluripotent stem cells." Doctoral thesis, Universitat de Barcelona, 2016. http://hdl.handle.net/10803/385921.
Full textEl corazón es el órgano más importante del cuerpo: impulsando la sangre, aporta oxigeno y nutrientes a cada célula del organismo. En caso de fallo cardiaco la función del corazón no puede recuperarse, ya que los cardiomiocitos son reemplazados por una cicatriz fibrosa no funcional. Las enfermedades cardiacas representan la mayor causa de muerte y enfermedad en el mundo occidental y entender los mecanismos de las patologías cardiacas, así como encontrar curas para ellas, es un desafío de primaria importancia para la medicina moderna. Siendo el corazón un órgano vital y difícilmente accesible, resulta imprescindible encontrar una fuente celular alternativa. Las células madre humanas con pluripotencia inducida (iPSC – induced pluripotent stem cells) parecen óptimas, porque se derivan de simples biopsias de piel de pacientes y se pueden diferenciar a cualquier tipo celular, cardiomiocitos incluidos. Aún así, diferenciar el tejido cardiaco es muy complejo: no solamente se debe de reproducir el tipo celular, sino también su composición celular, su arquitectura y sus funciones biofísicas. Para estudiar estos aspectos, por un lado obtuvimos tres líneas celulares de iPSC reporteras de genes específicos de diferentes estadios de diferenciación cardiaca (T para mesodermo, NKX2.5 para progenitores cardiacos y alpha-MHC para cardiomiocitos), y por otro desarrollamos un biorreactor adecuado para el cultivo de células cardiacas en 3D. Utilizamos las líneas transgénicas como herramienta para seleccionar células en diferentes estadios de diferenciación y las co-cultivamos con fibroblastos en un andamio compuesto de colágeno y elastina (imitando la matriz extracelular cardiaca y la composición celular del corazón). En conjunto, este estudio revela que las iPSC pueden ser retenidas y cultivadas en nuestro sistema 3D. Mientras células de mesodermo temprano y progenitores cardiacos no completaron la diferenciación cardiaca, los cardiomiocitos derivados de iPSC con cultivo convencional y cultivados en el biorreactor pudieron ser mantenidos viables en el mismo al menos 4 días. La aproximación experimental aquí presentada representa una base para desarrollar plataformas de estudio in vitro paciente-especificas para modelar enfermedades cardiacas humanas y estudios de fármacos, así como ofrecer una herramienta de estudio de los mecanismos de la diferenciación y maduración cardiacas.
Moncada, Diaz Silvia Juliana. "Repopulation and Stimulation of Porcine Cardiac Extracellular Matrix to Create Engineered Heart Patches." BYU ScholarsArchive, 2018. https://scholarsarchive.byu.edu/etd/8806.
Full textZakariyah, Abeer. "The Characterization of a Human Disease-Associated Mutation Nkx2.5 R142C Using In vitro and In vivo Models." Thesis, Université d'Ottawa / University of Ottawa, 2017. http://hdl.handle.net/10393/35817.
Full textSilva, Daniela Nascimento. "Isolamento e caracterização de células-tronco obtidas de corações de camundongos adultos." reponame:Repositório Institucional da FIOCRUZ, 2014. https://www.arca.fiocruz.br/handle/icict/8001.
Full textMade available in DSpace on 2014-07-21T17:48:02Z (GMT). No. of bitstreams: 1 Daniela Nascimento Siilva, Isolamento e caracterização... 2014a.pdf: 1250843 bytes, checksum: 1e4824ac04c822156d7a910d485dbc6b (MD5) Previous issue date: 2014
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil
O uso de células-tronco representa uma alternativa para o tratamento das doenças que acometem o coração, devido à capacidade que essas células indiferenciadas têm de preservar sua própria população e de se diferenciar em células dos diversos tecidos, incluindo o cardíaco. Nesse trabalho comparamos as características de células-tronco isoladas a partir do tecido cardíaco e da medula óssea de camundongos transgênicos para a proteína fluorescente verde (GFP). As células-tronco cardíacas e da medula óssea apresentaram característica morfológica fibroblastóide e imunofenotípica de células-tronco mesenquimais, com alta expressão dos marcadores CD44, CD90, CD73, Sca-1 e baixa expressão dos marcadores de células hematopoiéticas. A análise citogenética revelou um cariótipo poliplóide a partir da terceira passagem das células-tronco isoladas do coração e da medula-óssea. A capacidade de diferenciação em vários tipos celulares, tais como adipócitos, osteócitos e condrócitos, também foi avaliada nas células-tronco de ambas as fontes. Tanto as células-tronco isoladas do coração como da medula óssea foram capazes de se diferenciar nessas três linhagens. Quando estimuladas com 5’azacitidina para testar o potencial cardiomiogênico das células isoladas do coração e da medula óssea, apenas as células-tronco cardíacas passaram a expressar alguns marcadores de cardiomiócitos, tais como troponina T cardíaca e GATA-4. As células-tronco cardíacas GFP+ foram injetadas na parede lateral do ventrículo esquerdo de camundongos C57BL/6. Nenhum animal morreu durante o procedimento, e os parâmetros funcionais cardíacos mantiveram-se inalterados. Após 48 horas e uma semana depois da injeção foi possível observar células GFP+ em secções do miocárdio. Os resultados indicam que células-tronco isoladas do coração e da medula óssea possuem características similares, porém o potencial cardiomiogênico das células-tronco cardíacas é maior. A injeção intramiocárdica mostrou-se segura podendo ser candidata à via de administração de células no miocárdio. Novos estudos no campo da medicina regenerativa que visam a utilização de células-tronco cardíacas poderão ser úteis para demonstrar sua aplicação clínica como opção de tratamento para as doenças cardíacas.
Stem cells are undifferentiated cells with the ability of self-renewal and differentiation into different cell types, with the potential to treat heart diseases. In the present study we compared the characteristics of stem cells isolated from the heart to bone marrow stem cells, both obtained from EGFP transgeneic mice. Cardiac and bone marrow stem cells presented fibroblastic morphology and an immunophenotype compatible with mesenchymal stem cells – high expression of CD44, CD90, CD73, Sca-1 and low expression of of hematopoietic lineage markers. Cytogenetic analysis demonstrated polyploid karyotypes after the third passage of the stem cells isolated from heart and bone marrow. Both bone marrow and heart stem cells were able to differentiate into adipocytes, osteocytes and chondrocytes. In order to test the potential of differentiation into cardiomyocytes, cells were stimulated with 5’azacytidine and only cardiac stem cells expressed heart-specific markers: cardiac T troponin and GATA-4. GFP+ cardiac stem cells were injected into the lateral wall of the left ventricule of C57bl/6 mice. The procedure did not alter the functional cardiac parameters or induced mortality. GFP+ cells were observed in the heart 48 hours and seven days after the intramyocardial injection. The results indicate that cardiac stem cells and bone marrow stem cells are similar cell populations, although cardiac stem cells appear to have an increased cardiomyogenic potential. Intramyocardial injection was a safe and useful procedure for the transplantation of cardiac stem cells. New studies in the field of regenerative medicine aimed at the use of cardiac stem cells may be useful to demonstrate its clinical application as a treatment option for heart disease.
Bondue, Antoine. "Mesp1 functions in multipotent cardiovascular progenitor specification." Doctoral thesis, Universite Libre de Bruxelles, 2009. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/210319.
Full textDoctorat en sciences médicales
info:eu-repo/semantics/nonPublished
Paiva, Solenne. "Facteurs environnementaux et épigénétiques impliqués dans la différenciation cardiaque de cellules souches humaines pluripotentes induites MiRroring the Multiple Potentials of MicroRNAs in Acute Myocardial Infarction Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors." Thesis, Sorbonne université, 2019. http://www.theses.fr/2019SORUS457.
Full textThe objective of this thesis was to evaluate some physical and epigenetic parameters involved during cardiac differentiation of human induced pluripotent stem cells. Environmentally, an often undervalued physical parameter remains, the stiffness defined by the Young’s modulus. Commonly stem cells are cultured and adapted to in vitro rigidities ranging between 1-10 GPa very far from physiological values, for instance 10-15 kPa for the heart. The impact of soft culture substrates with 3 kPa, 12 kPa and 25 kPa was studied on the initial stem cells. Globally, results indicated that rigidities lower than 25 kPa were not suited for total pluripotency maintenance after 6 passages. Also, cellular colonies started to grow in 3D suggesting that softness drove them to build their own microenvironment. Epigenetically, the exact role of one of the first discovered microRNAs, the let-7 family has not yet been fully elucidated. Throughout differentiation its expression was characterized by an early transient peak at the time of mesoderm formation, after which their expression extinguished to only gradually re-increase later in the course of cardiomyocytes maturation. Modulation experiments involving mimics or inhibitors of the let-7 family on different cellular contexts suggested that initially let-7 acted on future cardiac specification but later, this family had to be repressed in order for cardiac progenitors to emerge. Oppositely, the cardiac specific miR-1 always contributed to their progression into cardiomyocytes. Together these researches contribute to fundamental research on human heart development and to applied research on human engineered cardiac tissues
Watson, Andrea. "Heat shock proteins in leukaemia cell differentiation and cell death." Thesis, Aston University, 1990. http://publications.aston.ac.uk/12533/.
Full textRao, Srinivas Venkateswarlu. "Examination of the role of porcine heat shock protein during adipocyte differentiation /." The Ohio State University, 1991. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487757723995836.
Full textDoroodian, Paymon. "Overexpression of Differentiation and Greening-Like Alters Stress Response of Arabidopsis thaliana." Ohio University / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ohiou1596227767908937.
Full textStiening, Chad Michael. "GENOMIC REGULATION OF BOVINE MAMMARY EPITHELIAL CELL GROWTH AND DIFFERENTIATION." Diss., Tucson, Arizona : University of Arizona, 2005. http://etd.library.arizona.edu/etd/GetFileServlet?file=file:///data1/pdf/etd/azu%5Fetd%5F1252%5F1%5Fm.pdf&type=application/pdf.
Full textGuyette, Jacques Paul. "Conditioning of Mesenchymal Stem Cells Initiates Cardiogenic Differentiation and Increases Function in Infarcted Hearts." Digital WPI, 2012. https://digitalcommons.wpi.edu/etd-dissertations/32.
Full textHosie, Andrew. "Differentiating thermal from non-thermal eccrine sweating during exercise and heat stress." Access electronically, 2002. http://www.library.uow.edu.au/adt-NWU/public/adt-NWU20041105.114628/index.html.
Full textHaddad, Nisrine. "The effects of heat-shock and differentiation on nuclear structure/functions in mammalian cellular systems." Thesis, University of Ottawa (Canada), 2002. http://hdl.handle.net/10393/6292.
Full textRusnak, Lauren Elizabeth. "Investigating Heat Shock Protein 70 as a Binding Partner of MK-STYX, and the Role of MK-STYX in Neuronal Differentiation." W&M ScholarWorks, 2013. https://scholarworks.wm.edu/etd/1539626944.
Full textHuber, Adrian Thomas. "Multi-organ non-invasive tissue characterization of fibrosis, adipose tissue, edema and inflammation with magnetic resonance (MR) imaging : applications to myocardium, skeletal muscle and liver interactions Cardiac MR strain: a noninvasive biomarker of fibro-fatty remodeling of the left atrial myocardium Comparison of MR T1 and T2 mapping parameters to characterize myocardial and skeletal muscle involvement in systemic Idiopathic Inflammatory Myopathy (IIM) Non-invasive differentiation of acute viral myocarditis and idiopathic inflammatory myopathy with cardiac involvement using magnetic resonance imaging T1 and T2 mapping CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuationbased quantitative scores in routine portal venous abdominal scans." Thesis, Sorbonne université, 2019. http://www.theses.fr/2019SORUS135.
Full textThis thesis provides a proof of concept for MR atrial strain, as well as MR relaxometry in the myocardium, in skeletal muscles and in the liver. Thanks to a close interaction between radiologist and software engineers, two different softwares were developed, applied and validated: one for multiorgan T1 mapping in the myocardium, skeletal muscle and liver, another one for cardiac four-chamber strain analysis and volumetry. The first publication showed a strong correlation of LA strain with the degree of fibro-fatty replacement in histology. Such functional imaging biomarker in combination with LA volumetry could help to guide clinical decisions, since myocardial structural remodeling is a known morphologic substrate of LA dysfunction, atrial fibrillation and adverse outcome. In the second publication, MR relaxometry parameters applied to the myocardium and skeletal muscles in IIM patients and healthy volunteers were used as a model to demonstrate influences of different tissue composition and vascularization on T1 mapping parameters. ΔT1 and EHF were introduced as simple alternatives to ECV in highly vascularized tissues such as the myocardium. In the third publication, MR relaxometry parameters applied to the skeletal muscls allowed for an accurate discrimination of AVM and IIM with cardiac involvement. However, when applied to the myocardium, parametric mapping did not separate between the two groups. The fourth publication introduced native T1 of the liver an easily accessible and accurate non-invasive imaging associate of congestive HF in IDCM patients with better performance than established functional parameters such as LV volumes, ejection fraction or strain
Mohammed, Sara Basher Taha [Verfasser]. "The Role of Heat Shock Protein 90 (HSP90) in the Transformation of Theileria annulata- infected Cells and the Parasite Stage Differentiation / Sara Basher Taha Mohammed." Berlin : Freie Universität Berlin, 2015. http://d-nb.info/1077478321/34.
Full textRaad, Farah. "Characterization and Application of Bioengineered Heart Muscle as a New Tool to Study Human Heart Development and Disease." Doctoral thesis, 2016. http://hdl.handle.net/11858/00-1735-0000-002B-7C05-A.
Full textLopes, Floro Kylie Biotechnology & Biomolecular Sciences Faculty of Science UNSW. "Dissecting the requirement for Cited2 during heart development and left-right patterning of the mouse embryo." 2007. http://handle.unsw.edu.au/1959.4/40531.
Full text"Gene expression profiles in neonatal heart development and functional roles of calcyclin binding protein/Siah-interacting protein in terminal differentiation of cardiomyocytes." 2004. http://library.cuhk.edu.hk/record=b6073675.
Full text"June 2004."
Thesis (Ph.D.)--Chinese University of Hong Kong, 2004.
Includes bibliographical references (p. 153-162).
Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web.
Mode of access: World Wide Web.
Abstracts in English and Chinese.
"Purification of cardiomyocytes derived from differentiated embryonic stem cells and study of the cytokines' effect on embryonic stem cell differentiation." 2008. http://library.cuhk.edu.hk/record=b5893596.
Full textThesis (M.Phil.)--Chinese University of Hong Kong, 2008.
Includes bibliographical references (leaves 144-153).
Abstracts in English and Chinese.
Abstract --- p.i
Abstract in Chinese (摘要) --- p.iii
Acknowledgements --- p.v
Table of Content --- p.vi
Abbreviations --- p.xv
Chapter CHAPTER 1 --- INTRODUCTION
Chapter 1.1 --- Stem cells --- p.1
Chapter 1.1.1 --- Adult stem cells --- p.2
Chapter 1.1.2 --- Embryonic stem cells --- p.2
Chapter 1.1.3 --- Pros and cons of embryonic and adult stem cells --- p.5
Chapter 1.1.4 --- Human embryonic stem cells (hESCs) --- p.6
Chapter 1.1.5 --- Mouse embryonic stem cells (mESCs) --- p.7
Chapter 1.1.6 --- Characteristics of ESC-derived cardiomyocytes --- p.7
Chapter 1.2 --- Cardiovascular Diseases (CVD) --- p.9
Chapter 1.2.1 --- Causes and statistics of CVD --- p.9
Chapter 1.2.2 --- Current treatment for CVD --- p.10
Chapter 1.2.3 --- Current hurdles of putting hESC-CMs into clinical use --- p.11
Chapter 1.3 --- Myosin light chain2v --- p.13
Chapter 1.4 --- Genetic-engineering of hESCs & their cardiac derivatives by lentiviral-mediate gene transfer --- p.14
Chapter 1.5 --- Cytokines secretion during myocardial infarction --- p.15
Chapter 1.6 --- Aims of the Project --- p.19
Chapter 1.7 --- Significance of the Project --- p.19
Chapter CHAPTER 2 --- MATERIALS AND METHODS
Chapter 2.1 --- Subcloning --- p.20
Chapter 2.1.1 --- Amplification of MLC-2v --- p.20
Chapter 2.1.2 --- Purification of DNA product --- p.21
Chapter 2.1.3 --- Restriction enzyme digestion --- p.21
Chapter 2.1.4 --- Ligation of MLC-2v promoter with DuetO 11 vector --- p.22
Chapter 2.1.5 --- Transformation of ligation product into competent cells --- p.22
Chapter 2.1.6 --- PCR confirmation of successful ligation --- p.23
Chapter 2.1.7 --- Small-scale preparation of bacterial plasmid DNA --- p.23
Chapter 2.1.8 --- Restriction enzyme digestions to reconfirm positive clones --- p.24
Chapter 2.1.9 --- DNA sequencing of the cloned plasmid DNA --- p.25
Chapter 2.1.10 --- Large-scale preparation of target recombinant expression vector --- p.25
Chapter 2.2 --- Mouse Embryonic Fibroblast (MEF) Culture --- p.26
Chapter 2.2.1 --- Derivation of MEF --- p.26
Chapter 2.2.2 --- Mouse embryonic fibroblast cells culture --- p.27
Chapter 2.2.3 --- Irradiation of mouse embryonic fibroblast --- p.28
Chapter 2.3 --- HESC culture --- p.29
Chapter 2.3.1 --- Thawing and Plating hESCs --- p.29
Chapter 2.3.2 --- Splitting hESCs --- p.30
Chapter 2.3.3 --- "Culture maintainence, selection and colony removal" --- p.31
Chapter a) --- Distinguish differentiated and undifferentiated cells and colonies
Chapter b) --- "Remove differentiated cells by ""Picking to Remove"""
Chapter c) --- "Remove undifferentiated cells by ""Picking to Keep"""
Chapter 2.3.4 --- Freezing hESCs --- p.31
Chapter 2.3.5 --- Differentiation of hESCs --- p.32
Chapter 2.3.6 --- "HESC culture on feeder free system, mTeSR TM1" --- p.34
Chapter a) --- Preparation of mTeSRTMl
Chapter b) --- Preparation of BD MatrigelTM hESC-qualified Matrix aliquots
Chapter c) --- Coating plates with BD MatrigelTM hESC-qualified Matrix
Chapter d) --- Human Embryonic stem cells culture in mTeSRTMl
Chapter 2.4 --- ES Cell Characterization (Chemicon Cat# SCR001) --- p.36
Chapter 2.4.1 --- Alkaline Phosphatase Staining --- p.36
Chapter 2.4.2 --- Immunofluorescence staining --- p.37
Chapter 2.5 --- MESC culture --- p.38
Chapter 2.5.1 --- Thawing and Plating mESCs --- p.38
Chapter 2.5.2 --- Splitting mESCs --- p.38
Chapter 2.5.3 --- Differentiation of mESCs --- p.39
Chapter 2.5.4 --- To study the effects of cytokines on mESC differentiation --- p.40
Chapter 2.6 --- Lentivirus (LV) Packaging --- p.41
Chapter 2.6.1 --- Transfection of lentiviral vectors into HEK293FT cells --- p.41
Chapter 2.6.2 --- LV titering --- p.42
Chapter 2.7 --- MultipleTransduction --- p.43
Chapter 2.8 --- Selection of transduced cells by hygromycin --- p.43
Chapter 2.8.1 --- Determination of hygromycin selection dosage --- p.43
Chapter 2.8.2 --- Selection of stable clones --- p.44
Chapter 2.9 --- Isolation of green fluorescent cardiomyocytes derived from differentiated hESCs --- p.45
Chapter 2.9.1 --- Collagenase digestion of embryoid bodies into single cells --- p.45
Chapter 2.9.2 --- FACS --- p.46
Chapter 2.10 --- Gene expression study
Chapter 2.10.1 --- Primer design --- p.46
Chapter 2.10.2 --- RNA extraction --- p.46
Chapter 2.10.3 --- DNase Treatment --- p.47
Chapter 2.10.4 --- Synthesis of Double-stranded cDNA from Total RNA --- p.47
Chapter 2.10.5 --- Quantitative real-time PCR --- p.48
Chapter 2.10.6 --- Quantification of mRNA expression --- p.49
Chapter 2.11 --- Protein Expression study --- p.49
Chapter 2.11.1 --- Crude protein extraction --- p.49
Chapter 2.11.2 --- Quantitation of protein samples --- p.50
Chapter 2.11.3 --- SDS-PAGE --- p.50
Chapter 2.11.4 --- Western Blot --- p.51
Chapter 2.11.5 --- Western blot luminal detection --- p.52
Chapter 2.11.6 --- Quantification of protein expression --- p.52
Chapter CHAPTER 3 --- PURIFICATION OF CARDIOMYOCYTES DERIVED FROM DIFFERENTIATED HESCs
Chapter 3.1 --- Subcloning --- p.57
Chapter 3.1.1 --- Linearization of DuetO11 and excision of UBC promoter --- p.58
Chapter 3.1.2 --- PCR cloning of MLC-2V --- p.59
Chapter 3.1.3 --- Ligation of MLC-2v promoter to linearized DuetO11 --- p.60
Chapter 3.1.3.1 --- Colony PCR to screen for positive clones --- p.61
Chapter 3.1.3.2 --- Restriction digestion to confirm the success of ligation --- p.61
Chapter 3.2 --- Lentivirus (LV) packaging --- p.62
Chapter 3.2.1 --- Transfection --- p.63
Chapter 3.2.2 --- LV titering --- p.64
Chapter 3.3 --- HESC culture --- p.66
Chapter 3.4 --- Multi-transduction of hESCs with LVs --- p.67
Chapter 3.5 --- Differentiation after transduction --- p.69
Chapter 3.6 --- Antibiotic selection --- p.71
Chapter 3.6.1 --- Characterization of hESCs on feeder free system --- p.72
Chapter 3.6.1.1 --- Alkaline Phosphatase (AP) staining --- p.72
Chapter 3.6.1.2 --- Immunostaining with pluripotency marker --- p.73
Chapter 3.6.2 --- Determination of hygromycin dosage by MTT assay --- p.74
Chapter 3.6.3 --- HESCs after selection in feeder free system --- p.75
Chapter 3.7 --- Differentiation of hESCs after selection --- p.76
Chapter 3.8 --- FACS --- p.77
Chapter 3.9 --- QPCR of cells after FACS --- p.80
Chapter 3.9.1 --- Gene expression of Nkx2.5 --- p.81
Chapter 3.9.2 --- Gene expression of c-Tnl --- p.82
Chapter 3.9.3 --- Gene expression of c-TnT --- p.83
Chapter 3.9.3 --- Gene expression of MLC-2v --- p.84
Chapter CHAPTER 4 --- THE STUDY OF CYTOKINES' EFFECT ON MESC DIFFERENTIATION
Chapter 4.1 --- mESC culture --- p.85
Chapter 4.2 --- The effect of cytokines on the differentiation of mESCs --- p.86
Chapter 4.2.1 --- Beating curves of mESCs treated with different concentrations of cytokines at differentiation day 2 to 6 before attachment --- p.88
Chapter 4.2.2 --- qPCR to determine the cytokines' effect on the differentiation of mESCs --- p.94
Chapter 4.2.2.1 --- The effect of IL-1α on the expression of cardiac specific genes --- p.95
Chapter 4.2.2.2 --- The effect of IL-1β on the expression of cardiac specific genes --- p.98
Chapter 4.2.2.3 --- The effect of IL-6 on the expression of cardiac specific genes --- p.101
Chapter 4.2.2.4 --- The effect of IL-10 on the expression of cardiac specific genes --- p.104
Chapter 4.2.2.5 --- The effect of IL-18 on the expression of cardiac specific genes --- p.107
Chapter 4.2.2.6 --- The effect of TNF-α on the expression of cardiac specific genes --- p.110
Chapter 4.2.3 --- Western blot analysis of the cytokines' effect on the differentiation of mESCs --- p.113
Chapter 4.2.3.1 --- The effect of IL-lα on the abundance of cardiac specific proteins --- p.114
Chapter 4.2.3.2 --- The effect of IL-1β on the abundance of cardiac specific proteins --- p.116
Chapter 4.2.3.3 --- The effect of IL-6 on the abundance of cardiac specific proteins --- p.118
Chapter 4.2.3.4 --- The effect of IL-10 on the abundance of cardiac specific proteins --- p.120
Chapter 4.2.3.5 --- The effect of IL-18 on the abundance of cardiac specific proteins --- p.122
Chapter 4.2.3.6 --- The effect of TNF-α on the abundance of cardiac specific proteins --- p.124
Chapter CHAPTER 5 --- DISCUSSION
Chapter 5.1 --- Purification of cardiomyocytes derived from differentiated hESCs --- p.127
Chapter 5.2 --- Study on the effect of cytokines on mESC differentiation --- p.135
Chapter 5.3 --- Conclusion --- p.142
REFERENCES --- p.144
"Role of reactive oxygen species (ROS) in cardiomyocyte differentiation of mouse embryonic stem cells." 2009. http://library.cuhk.edu.hk/record=b5894101.
Full textThesis (M.Phil.)--Chinese University of Hong Kong, 2009.
Includes bibliographical references (leaves 111-117).
Abstract also in Chinese.
Thesis Committee --- p.i
Acknowledgements --- p.ii
Contents --- p.iii
Abstract --- p.vii
論文摘要 --- p.x
Abbreviations --- p.xi
List of Figures --- p.xiii
List of Tables --- p.xxiii
Chapter CHAPTER ONE --- INTRODUCTION
Chapter 1.1 --- Embryonic Stem (ES) Cells
Chapter 1.1.1 --- Characteristics of ES Cells l
Chapter 1.1.2 --- Therapeutic Potential of ES Cells --- p.3
Chapter 1.1.3 --- Myocardial Infarction and ES cells-derived Cardiomyocytes --- p.4
Chapter 1.1.4 --- Current Hurdles of Using ES cells-derived Cardiomyocytes for Research and Therapeutic Purposes --- p.6
Chapter 1.2 --- Transcription Factors for Cardiac Development
Chapter 1.2.1 --- GATA-binding Protein 4 (GATA-4) --- p.8
Chapter 1.2.2 --- Myocyte Enhancer Factor 2C (MEF2C) --- p.10
Chapter 1.2.3 --- "NK2 Transcription Factor Related, Locus 5 (Nkx2.5)" --- p.11
Chapter 1.2.4 --- Heart and Neural Crest Derivatives Expressed 1 /2 (HANDI/2) --- p.11
Chapter 1.2.5 --- T-box Protein 5 (Tbx5) --- p.13
Chapter 1.2.6 --- Serum Response Factor (SRF) --- p.14
Chapter 1.2.7 --- Specificity Protein 1 (Spl) --- p.15
Chapter 1.2.8 --- Activator Protein 1 (AP-1) --- p.16
Chapter 1.3 --- Reactive Oxygen Species (ROS)
Chapter 1.3.1 --- Cellular Production of ROS --- p.18
Chapter 1.3.2 --- Maintenance of Redox balance --- p.18
Chapter 1.3.3 --- Redox Signaling --- p.19
Chapter 1.4 --- Nitric Oxide (NO) and NO Signaling --- p.20
Chapter 1.5 --- Aims of the Study --- p.22
Chapter CHAPTER TWO --- MATERIALS AND METHODS
Chapter 2.1 --- Mouse Embryonic Fibroblast (MEF) Culture
Chapter 2.1.1 --- Derivation of MEF --- p.23
Chapter 2.1.2 --- Maintenance of MEF Culture --- p.24
Chapter 2.1.3 --- Irradiation of MEF --- p.25
Chapter 2.2 --- Mouse ES Cell Culture
Chapter 2.2.1 --- Maintenance of Undifferentiated Mouse ES Cell Culture --- p.26
Chapter 2.2.2 --- Differentiation of Mouse ES Cells --- p.26
Chapter 2.2.3 --- Exogenous addition of hydrogen peroxide (H2O2) and NO --- p.27
Chapter 2.3 --- ROS Localization Study
Chapter 2.3.1 --- Frozen Sectioning --- p.28
Chapter 2.3.2 --- Confocal microscopy for ROS detection --- p.28
Chapter 2.4 --- Intracellular ROS Measurement
Chapter 2.4.1 --- "Chemistry of 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA)" --- p.29
Chapter 2.4.2 --- Flow Cytometry for ROS Measurement --- p.29
Chapter 2.5 --- Gene Expression Study
Chapter 2.5.1 --- Primer Design --- p.30
Chapter 2.5.2 --- RNA Extraction --- p.31
Chapter 2.5.3 --- DNase Treatment --- p.32
Chapter 2.5.4 --- Reverse Transcription --- p.32
Chapter 2.5.5 --- Quantitative Real Time PCR --- p.33
Chapter 2.5.6 --- Quantification of mRNA Expression --- p.34
Chapter 2.6 --- Protein Expression Study
Chapter 2.6.1 --- Total Protein Extraction --- p.34
Chapter 2.6.2 --- Nuclear and Cytosolic Protein Extraction --- p.35
Chapter 2.6.3 --- Measurement of Protein Concentration --- p.36
Chapter 2.6.4 --- De-sumoylation Assay --- p.36
Chapter 2.6.5 --- De-phosphorylation Assay --- p.37
Chapter 2.6.6 --- De-glycosylation Assay --- p.38
Chapter 2.6.7 --- Western Blot --- p.39
Chapter 2.7 --- Statistical Analysis --- p.41
Chapter CHAPTER THREE --- RESULTS
Chapter 3.1 --- Study of Endogenous ROS
Chapter 3.1.1 --- Level and Distribution of Endogenous ROS --- p.47
Chapter 3.1.2 --- Quantification of intracellular ROS --- p.48
Chapter 3.2 --- Effect of Exogenous Addition of Nitric Oxide (NO) on Cardiac Differentiation
Chapter 3.2.1 --- Beating Profile of NO-treated Embryoid Bodies (EBs) --- p.50
Chapter 3.3 --- Effect of Exogenous Addition of H2O2 on Cardiac Differentiation
Chapter 3.3.1 --- Beating Profile of H2O2-treated EBs --- p.51
Chapter 3.3.2 --- mRNA Expression of Cardiac Structural Genes --- p.52
Chapter 3.3.3 --- Protein Expression of Cardiac Structural Genes --- p.54
Chapter 3.3.4 --- mRNA Expression of Cardiac Transcription Factors --- p.58
Chapter 3.3.5 --- Protein Expression of Cardiac Transcription Factors --- p.67
Chapter 3.3.6 --- Post-translational Modifications of Cardiac Transcription Factors --- p.74
Chapter 3.3.7 --- Translocation of Cardiac Transcription Factors --- p.89
Chapter CHAPTER FOUR --- DISCUSSION
Chapter 4.1 --- Changes in the Level of Endogenous ROS During Cardiac Differentiation of Mouse ES Cells --- p.96
Chapter 4.2 --- H2O2 and NO Have Opposite Effects Towards Cardiac Differentiation --- p.97
Chapter 4.3 --- Exogenous Addition of H2O2 Advances Differentiation of Mouse ES Cells into Cardiac Lineage --- p.99
Chapter 4.4 --- Possible Role of H2O2 in Mediating Cardiac Differentiation of Mouse ES Cells --- p.103
Chapter 4.5 --- Future Directions --- p.108
Conclusions --- p.110
References --- p.111
"Mechanisms underlying the self-renewal characteristic and cardiac differentiation of mouse embryonic stem cells." 2009. http://library.cuhk.edu.hk/record=b5896594.
Full textThesis (M.Phil.)--Chinese University of Hong Kong, 2009.
Includes bibliographical references (leaves 110-124).
Abstract also in Chinese.
Thesis Committee --- p.i
Acknowledgements --- p.ii
Contents --- p.iii
Abstract --- p.vii
論文摘要 --- p.x
Abbreviations --- p.xi
List of Figures --- p.xiii
List of Tables --- p.xvii
Chapter CHAPTER ONE --- INTRODUCTION --- p.1
Chapter 1.1 --- Embryonic Stem Cells (ESCs) --- p.1
Chapter 1.1.1 --- What are ESCs and the characteristics of ESCs --- p.1
Chapter 1.1.1.1 --- Pluripotent markers --- p.2
Chapter 1.1.1.2 --- Germ layers' markers --- p.3
Chapter 1.1.2 --- Mouse ESCs (mESCs) --- p.4
Chapter 1.1.2.1 --- mESCs co-culture with mitotically inactivated mouse embryonic fibroblast (MEF) feeder layers --- p.4
Chapter 1.1.2.2 --- Feeder free mESCs --- p.4
Chapter 1.1.3 --- Promising uses of ESCs and their shortcomings --- p.5
Chapter 1.1.4 --- Characteristics of ESC-derived cardiomyocytes (ESC-CMs) --- p.6
Chapter 1.2 --- Cardiovascular diseases (CVD) --- p.7
Chapter 1.2.1 --- Background --- p.7
Chapter 1.2.2 --- Current treatments --- p.8
Chapter 1.2.3 --- Potential uses of ESC-CMs for basic science research and therapeutic purposes --- p.9
Chapter 1.2.4 --- Current hurdles in application of ESC-CMs for clinical uses --- p.10
Chapter 1.3 --- Cardiac gene markers --- p.13
Chapter 1.3.1 --- Atrial-specific --- p.13
Chapter 1.3.2 --- Ventricular-specific --- p.19
Chapter 1.4 --- Lentiviral vector-mediated gene transfer --- p.27
Chapter 1.5 --- Cell cycle in ESCs --- p.29
Chapter 1.5.1 --- Cell cycle --- p.29
Chapter 1.5.2 --- Characteristics of cell cycle in ESCs --- p.30
Chapter 1.6 --- Potassium (K+) channels --- p.31
Chapter 1.6.1 --- Voltage gated potassium (Kv) channels --- p.32
Chapter 1.6.2 --- Role of Kv channels in maintenance of membrane potential --- p.32
Chapter 1.7 --- Objectives and significances --- p.33
Chapter CHAPTER TWO --- MATERIALS AND METHODS --- p.35
Chapter 2.1 --- Mouse embryonic fibroblast (MEF) culture --- p.35
Chapter 2.1.1 --- Derivation of MEF --- p.3 5
Chapter 2.1.2 --- MEF culture --- p.37
Chapter 2.1.3 --- Irradiation of MEF --- p.37
Chapter 2.2 --- mESC culture and their differentiation --- p.38
Chapter 2.2.1 --- mESC culture --- p.38
Chapter 2.2.2 --- Differentiation of mESCs --- p.39
Chapter 2.3 --- Subcloning --- p.40
Chapter 2.3.1 --- Amplification of Irx4 --- p.40
Chapter 2.3.2 --- Purification of DNA products --- p.41
Chapter 2.3.3 --- Restriction enzyme digestion --- p.42
Chapter 2.3.4 --- Ligation of Irx4 with iDuet101A vector --- p.43
Chapter 2.3.5 --- Transformation of ligation product into competent cells --- p.43
Chapter 2.3.6 --- Small scale preparation of bacterial plasmid DNA --- p.44
Chapter 2.3.7 --- Confirmation of positive clones by restriction enzyme digestion --- p.45
Chapter 2.3.8 --- DNA sequencing of the cloned plasmid DNA --- p.45
Chapter 2.3.9 --- Large scale preparation of target recombinant expression vector --- p.45
Chapter 2.4 --- Lentiviral vector-mediated gene transfer to mESCs --- p.47
Chapter 2.4.1 --- Lentivirus packaging --- p.47
Chapter 2.4.2 --- Lentivirus titering --- p.48
Chapter 2.4.3 --- Multiple transduction to mESCs --- p.48
Chapter 2.4.4 --- Hygromycin selection on mESCs --- p.49
Chapter 2.5 --- Selection of stable clone --- p.49
Chapter 2.5.1 --- Monoclonal establishment and clone selection --- p.49
Chapter 2.6 --- Differentiation of cell lines after selection --- p.50
Chapter 2.7 --- Gene expression study on control and Irx4-overexpressed mESC lines --- p.50
Chapter 2.8 --- Analysis of mESCs at different phases of the cell cycle --- p.55
Chapter 2.8.1 --- Go/Gi and S phase synchronization --- p.55
Chapter 2.8.2 --- Cell cycle analysis by propidium iodide (PI) staining followed by flow cytometric analysis --- p.55
Chapter 2.8.3 --- Gene expression study by qPCR of Kv channel isoforms --- p.56
Chapter 2.8.4 --- Membrane potential measurement by membrane potential-sensitive dye followed by flow cytometry --- p.57
Chapter 2.9 --- Apoptotic study --- p.58
Chapter 2.10 --- Determination of pluripotent characteristic of mESCs --- p.59
Chapter 2.10.1 --- Expression of germ layers' markers by qPCR --- p.59
Chapter 2.10.2 --- Differentiation by hanging drop method and suspension method --- p.61
Chapter CHAPTER THREE --- RESULTS --- p.62
Chapter 3.1 --- mESC culture --- p.62
Chapter 3.1.1 --- Cell colony morphology of feeder free mESCs --- p.62
Chapter 3.2 --- Subcloning --- p.63
Chapter 3.2.1 --- PCR cloning of Irx4 --- p.63
Chapter 3.2.2 --- Restriction digestion on iDuet101A --- p.64
Chapter 3.2.3 --- Ligation of Irx4 to iDuet101A backbone --- p.66
Chapter 3.2.4 --- Confirmation of successful ligation --- p.67
Chapter 3.3 --- Lentivirus packaging --- p.68
Chapter 3.3.1 --- Transfection --- p.68
Chapter 3.4 --- Multiple transduction of mESCs and hygromycin selection of positively-transduced cells --- p.69
Chapter 3.5 --- FACS --- p.70
Chapter 3.6 --- Irx4 and iduet clone selection --- p.71
Chapter 3.7 --- Characte rization of mESCs after clone selection --- p.74
Chapter 3.7.1 --- Immunostaining of pluripotent and differentiation markers --- p.74
Chapter 3.8 --- Differentiation of cell lines after selection --- p.77
Chapter 3.8.1 --- Size of EBs of the cell lines during differentiation --- p.77
Chapter 3.9 --- Gene expression study by qPCR --- p.79
Chapter 3.10 --- Kv channel expression and membrane potential of mESCs at Go/Gi phase and S phases --- p.84
Chapter 3.10.1 --- Expression of Kv channels subunits at G0/Gi phase and S phase --- p.86
Chapter 3.10.2 --- Membrane potential at Go/Gi phase and S phase --- p.87
Chapter 3.11 --- Effects of TEA+ on feeder free mESCs --- p.89
Chapter 3.11.1 --- Apoptotic study --- p.89
Chapter 3.11.2 --- Expression of germ layers´ة markers --- p.91
Chapter 3.11.3 --- Embryo id bodies (EBs) measurement after differentiation --- p.92
Chapter CHAPTER FOUR --- DISCUSSION --- p.95
Chapter 4.1 --- Effect of overexpression of Irx4 on the cardiogenic potential of mESCs --- p.95
Chapter 4.2 --- Role of Kv channels in maintaining the chacteristics of mESCs --- p.99
Chapter 4.2.1 --- Inhibition of Kv channels led to a redistribution of the proportion of cells in different phases of the cell cycle: importance of Kv channels in cell cycle progression in native ESCs --- p.99
Chapter 4.2.2 --- Inhibition of Kv channels led to a loss of pluripotency at molecular and functional levels: importance of Kv channels in the fate determination of mESCs --- p.102
Chapter 4.3 --- Insights from the present investigation on the future uses of ESCs --- p.105
Conclusions --- p.108
References --- p.110
Lajiness, Jacquelyn D. "Shp2 deletion in post-migratory neural crest cells results in impaired cardiac sympathetic innervation." Thesis, 2014. http://hdl.handle.net/1805/5495.
Full textAutonomic innervation of the heart begins in utero and continues during the neonatal phase of life. A balance between the sympathetic and parasympathetic arms of the autonomic nervous system is required to regulate heart rate as well as the force of each contraction. Our lab studies the development of sympathetic innervation of the early postnatal heart in a conditional knockout (cKO) of Src homology protein tyrosine phosphatase 2 (Shp2). Shp2 is a ubiquitously expressed non-receptor phosphatase involved in a variety of cellular functions including survival, proliferation, and differentiation. We targeted Shp2 in post-migratory neural crest (NC) lineages using our novel Periostin-Cre. This resulted in a fully penetrant mouse model of diminished cardiac sympathetic innervation and concomitant bradycardia that progressively worsen. Shp2 is thought to mediate its basic cellular functions through a plethora of signaling cascades including extracellular signal-regulated kinases (ERK) 1 and 2. We hypothesize that abrogation of downstream ERK1/2 signaling in NC lineages is primarily responsible for the failed sympathetic innervation phenotype observed in our mouse model. Shp2 cKOs are indistinguishable from control littermates at birth and exhibit no gross structural cardiac anomalies; however, in vivo electrocardiogram (ECG) characterization revealed sinus bradycardia that develops as the Shp2 cKO ages. Significantly, 100% of Shp2 cKOs die within 3 weeks after birth. Characterization of the expression pattern of the sympathetic nerve marker tyrosine hydroxylase (TH) revealed a loss of functional sympathetic ganglionic neurons and reduction of cardiac sympathetic axon density in Shp2 cKOs. Shp2 cKOs exhibit lineage-specific suppression of activated pERK1/2 signaling, but not of other downstream targets of Shp2 such as pAKT (phosphorylated-Protein kinase B). Interestingly, restoration of pERK signaling via lineage-specific expression of constitutively active MEK1 (Mitogen-activated protein kinase kinase1) rescued TH-positive cardiac innervation as well as heart rate. These data suggest that the diminished sympathetic cardiac innervation and the resulting ECG abnormalities are a result of decreased pERK signaling in post-migratory NC lineages.
Lankeit, Mareike Katharina. "Neue Biomarker und Multimarkerstrategien für eine optimierte Risikostratifizierung von Patienten mit Lungenembolie." Doctoral thesis, 2010. http://hdl.handle.net/11858/00-1735-0000-0006-AF7C-A.
Full textKang, Susey H. "Characterization of gene expression profiles during differentiation, lipopolysaccharide stimulation, and heat shock repression in human U937 monocyte cells." 2004. http://link.library.utoronto.ca/eir/EIRdetail.cfm?Resources__ID=95285&T=F.
Full textKaiser, Diana. "Der Einfluss mechanischer Last auf das Potential multipotenter adulter Keimbahnstammzellen zur kardialen Regeneration." Doctoral thesis, 2011. http://hdl.handle.net/11858/00-1735-0000-0006-ADEB-D.
Full textMontgomery, Amy. "Combining induced pluripotent stem cells and fibrin matrices for spinal cord injury repair." Thesis, 2014. http://hdl.handle.net/1828/5272.
Full textGraduate
0541
amy.lynn.montgomery@gmail.com